Severe late onset capillary leak syndrome post allo-HSCT successfully treated by bevacizumab: a case report
Frontiers in Medicine · 07.01.2025 · 11
DOI: 10.3389/fmed.2024.1483064 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Medicine, online erschienen am 07.01.2025. Verfasst von Song Xue und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bone Marrow Transplant, Beijing Lu Daopei Hospital, Beijing, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This article describes a case of successful management of late-onset CLS occurring after allo-HSCT, employing bevacizumab as the therapeutic agent. Capillary leak syndrome (CLS) represents a critical complication arising from allogeneic hematopoietic stem cell transplantation (allo-HSCT). The prognosis for CLS remains considerably constrained. A targeted therapeutic approach targeting vascular endothelial growth factor (VEGF) offers a novel strategy for the management of CLS.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Bone Marrow Transplant, Beijing Lu Daopei Hospital, Beijing, China.
- Department of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China.
- Department of Radiology, Beijing Lu Daopei Hospital, Beijing, China.
- Division of Pathology and Laboratory Medicine, Beijing Lu Daopei Hospital, Beijing, China.
- Department of Bone Marrow Transplant, Hebei Yanda Lu Daopei Hospital, Langfang, China.
- Pharmacy Department, Beijing Lu Daopei Hospital, Beijing, China.
Zitieren
APA
Xue, S., Chen, J., Shi, Y., Zhang, L., Chen, M., Sun, H., Cao, X., & Wu, F. (2025). Severe late onset capillary leak syndrome post allo-HSCT successfully treated by bevacizumab: a case report. Frontiers in Medicine, 11. https://doi.org/10.3389/fmed.2024.1483064
Vancouver
Xue S, Chen J, Shi Y, Zhang L, Chen M, Sun H, et al. Severe late onset capillary leak syndrome post allo-HSCT successfully treated by bevacizumab: a case report. Frontiers in Medicine. 2025;11. doi:10.3389/fmed.2024.1483064
BibTeX
@article{Xue2025,
author = {Xue, Song and Chen, Jiaqi and Shi, Yuzhu and Zhang, Lina and Chen, Man and Sun, Huipeng and Cao, Xingyu and Wu, Fang},
title = {Severe late onset capillary leak syndrome post allo-HSCT successfully treated by bevacizumab: a case report},
journal = {Frontiers in Medicine},
year = {2025},
volume = {11},
doi = {10.3389/fmed.2024.1483064}
}
EUVIMED